Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Dutch research and development vaccine institute Intravacc has collaborated with Wageningen Bioveterinary Research (WBVR) and Utrecht University to develop an intranasal vaccine against Covid-19.
The alliance will combine Intravacc’s vaccine development technology, WBVR’s viral vector and animal technologies, along with Utrecht University’s coronavirus expertise.
Intravacc noted that the intranasal vaccine will contain a Newcastle disease virus (NDV) vector that expresses the SARS-CoV-2’s immunogenic spike (S) protein, a key target for neutralising antibodies.